tiprankstipranks
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
TSE/TYO:2395
Japanese Market

Shin Nippon Biomedical Laboratories, Ltd. (2395) Stock Price & Analysis

0 Followers

2395 Stock Chart & Stats

Day’s Range¥0 - ¥0
52-Week Range¥1,286.00 - ¥2,391.88
Previous Close¥1,424
Volume281.40K
Average Volume (3M)254.68K
Market Cap
¥59.28B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.7
Beta0.94
Jul 31, 2024
EPS EstimateN/A
Dividend Yield3.51%
Share Statistics
EPS (TTM)132.86
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume254,683
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Shin Nippon Biomedical Laboratories, Ltd. News

Options Prices

Currently, No data available
---

Ownership Overview

0.00%1.51%2.57%95.93%
0.00%
Insiders
2.57% Other Institutional Investors
95.93% Public Companies and
Individual Investors

2395 FAQ

What was Shin Nippon Biomedical Laboratories, Ltd.’s price range in the past 12 months?
Shin Nippon Biomedical Laboratories, Ltd. lowest stock price was ¥1286.00 and its highest was ¥2391.88 in the past 12 months.
    What is Shin Nippon Biomedical Laboratories, Ltd.’s market cap?
    Currently, no data Available
    When is Shin Nippon Biomedical Laboratories, Ltd.’s upcoming earnings report date?
    Shin Nippon Biomedical Laboratories, Ltd.’s upcoming earnings report date is Jul 31, 2024 which is in 30 days.
      How were Shin Nippon Biomedical Laboratories, Ltd.’s earnings last quarter?
      Shin Nippon Biomedical Laboratories, Ltd. released its earnings results on May 08, 2024. The company reported ¥12.986 earnings per share for the quarter, the consensus estimate of ¥12.986 by ¥0.
        Is Shin Nippon Biomedical Laboratories, Ltd. overvalued?
        According to Wall Street analysts Shin Nippon Biomedical Laboratories, Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Shin Nippon Biomedical Laboratories, Ltd. pay dividends?
          Shin Nippon Biomedical Laboratories, Ltd. pays a Annually dividend of ¥30 which represents an annual dividend yield of 3.51%. See more information on Shin Nippon Biomedical Laboratories, Ltd. dividends here
            What is Shin Nippon Biomedical Laboratories, Ltd.’s EPS estimate?
            Shin Nippon Biomedical Laboratories, Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Shin Nippon Biomedical Laboratories, Ltd. have?
            Shin Nippon Biomedical Laboratories, Ltd. has 41,632,400 shares outstanding.
              What happened to Shin Nippon Biomedical Laboratories, Ltd.’s price movement after its last earnings report?
              Shin Nippon Biomedical Laboratories, Ltd. reported an EPS of ¥12.986 in its last earnings report, expectations of ¥12.986. Following the earnings report the stock price went down -6.37%.
                Which hedge fund is a major shareholder of Shin Nippon Biomedical Laboratories, Ltd.?
                Currently, no hedge funds are holding shares in JP:2395
                ---

                Shin Nippon Biomedical Laboratories, Ltd. Stock Smart Score

                Similar Stocks
                Company
                Price & Change
                Follow
                Taiyo Holdings Co., Ltd.
                RaQualia Pharma Inc.
                KYORIN Pharmaceutical Co.,Ltd.
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis